Table 4:
Parameter | AUC | Standard Error | p-value | p-value corrected |
---|---|---|---|---|
Anatomic Dose | ||||
MLD | 0.94 | 0.090 | 0.0025 | 0.013 |
V20 | 0.96 | 0.066 | 0.0016 | 0.013 |
Functional Baseline FDG | ||||
SUVmean | 0.55 | 0.18 | 0.75 | 0.81 |
GLPG | 0.65 | 0.14 | 0.31 | 0.55 |
Coefficient of Variation | 0.36 | 0.20 | 0.34 | 0.55 |
Skewness | 0.57 | 0.20 | 0.63 | 0.73 |
Kurtosis | 0.58 | 0.18 | 0.59 | 0.72 |
Functional Baseline PERF | ||||
Coefficient of Variation | 0.65 | 0.11 | 0.29 | 0.55 |
Skewness | 0.47 | 0.16 | 0.83 | 0.83 |
Kurtosis | 0.40 | 0.18 | 0.49 | 0.65 |
Functional Dose FDG | ||||
sMLD | 0.83 | 0.12 | 0.025 | 0.057 |
sV20 | 0.75 | 0.14 | 0.089 | 0.18 |
sF20 | 0.97 | 0.04 | 0.0014 | 0.013 |
Functional Dose PERF | ||||
pMLD | 0.84 | 0.13 | 0.018 | 0.048 |
pV20 | 0.86 | 0.11 | 0.013 | 0.041 |
pF20 | 0.87 | 0.11 | 0.011 | 0.041 |
Significant predictors of GR2+ PNM highlighted in gray. sMLD did not remain significant after Benjamini-Hochberg correction for false discovery rate.